Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Nocturia: New Directions
J. Weiss, A. Wein, P. V. van Kerrebroeck, R. Dmochowski, M. Fitzgerald, K. Tikkinen, P. Abrams
Published 2011 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The Nocturia Think Tank (TT) met during the 2010 meeting of the International Consultation on Incontinence‐Research Society to discuss present knowledge and future directions in care and research of this prominent component of the spectrum of lower urinary tract symptoms. Questions raised included whether nocturia should be re‐defined as a function of its bother, effects on quality of life, and economic impact upon society. At issue is the need to delineate the determinants of successful nocturia management. The multifactorial nature of nocturia requires that progress in its treatment will be dependent upon the cooperative investigation on the part of urologists, urogynecologists, geriatricians, epidemiologists, medical economists and pharma. Areas for future avenues of research were outlined at the conclusion of the meeting. Neurourol. Urodynam. Neurourol. Urodynam. 30:700–703, 2011. © 2011 Wiley‐Liss, Inc.
This paper references
2 ECONOMIC BURDEN OF NOCTURIA IN THE US ADULT POPULATION
T. Holm-Larsen (2010)
Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms
L. Brubaker (2006)
3-Year follow-up of urinary symptoms after transurethral resection of the prostate
RC Bruskewitz (1986)
Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population.
M. H. Bing (2006)
Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS).
J. Häkkinen (2008)
Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder.
R. Dmochowski (2010)
Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy.
H. Koseoglu (2006)
The standardisation of terminology in nocturia: Report from the standardisation sub‐committee of the International Continence Society
P. V. van Kerrebroeck (2002)
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
Daniel J Buysse (1989)
1528 FAST-DISSOLVING DESMOPRESSIN (MELT) IS WELL TOLERATED IN NOCTURIA: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED STUDY
J. Weiss (2010)
[Nocturia and benign prostatic hyperplasia].
D. Laketić (2008)
Mortality in the elderly correlates with the frequency of nighttime voiding: Results of a 3-year prospective cohort study in Japan
H Nakagawa (2010)
The 15D instrument of health-related quality of life: properties and applications
H. Sintonen (2001)
A Systematic Evaluation of Factors Associated With Nocturia—The Population-based FINNO Study
K. Tikkinen (2009)
Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland.
K. Tikkinen (2010)
The physiology of sleep and the impact of ageing
N. Stanley (2005)
Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
T. Johnson (2003)
Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project.
G. Schatzl (2000)
Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia.
R. Rackley (2006)
Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
P. V. van Kerrebroeck (2007)
The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.
T. Johnson (2007)
Standardisation of terminology of nocturia
P van Kerrebroeck (2002)
Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia
G. Kobelt (2003)
CLINICAL UROLOGY: Review ArticleNOCTURIA
J. P. Weiss (2000)
The Standardization of Terminology for Researchers in Female Pelvic Floor Disorders
A. Weber (2001)
Development and validation of a quality-of-life measure for men with nocturia.
L. Abraham (2004)
The effect of nocturia on sleep.
S. Ancoli-Israel (2011)
The pharmacological treatment of nocturia
K. Andersson (2002)
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
S. Kaplan (2006)
Efficacy and safety of tamsulosin OCAS
M. Speakman (2006)
Impact of surgical treatment on nocturia in men with benign prostatic obstruction
T. Cai (2006)
3-year followup of urinary symptoms after transurethral resection of the prostate.
R. Bruskewitz (1986)
Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder.
L. Cardozo (2004)
Antidiuresis therapy: Mechanism of action and clinical implications
J. Nørgaard (2007)
Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey.
V. Kupelian (2011)
3 MORTALITY IN THE ELDERLY CORRELATES WITH THE FREQUENCY OF NIGHTTIME VOIDING: RESULTS OF A 5-YEAR PROSPECTIVE COHORT STUDY IN JAPAN
H. Nakagawa (2010)
Nocturia: A Risk Factor for Falls in the Elderly
R. B. Stewart (1992)
The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey.
M. Fitzgerald (2007)
1529 NOVEL NON-PEPTIDE PHARMACOLOGIC THERAPY FOR NOCTURIA IN MEN
Mariam Imnadze (2010)
Guidelines on Conservative Treatment of Non-neurogenic Male LUTS
M. Oelke (2010)
Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older.
Hong-Jeng Yu (2006)
Is nocturia equally common among men and women? A population based study in Finland.
K. Tikkinen (2006)
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial
S. Herschorn (2010)
Nocturia: Diagnosis and management
CL Lee (2009)
This paper is referenced by
Epidemiology of Nocturia: Evaluation of Prevalence, Incidence, Impact and Risk Factors
Kari A.O. Tikkinen (2012)
Nocturia in Patients With Parkinson's Disease
M. Smith (2016)
Nocturia: Current Evaluation and Treatment for Urology
Tony Nimeh (2015)
A cutoff value based on analysis of a reference population decreases overestimation of the prevalence of nocturnal polyuria.
E. P. van Haarst (2012)
Current pharmacotherapy of nocturia
A. Smith (2013)
Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α‐blocker therapy in men with nocturia
T. Johnson (2013)
Combination therapies for the management of nocturia and its comorbidities
C. Yazici (2015)
Hidden prevalence of lower urinary tract symptoms in healthy nulligravid young women
Hendrikje M. K. van Breda (2015)
The fluctuation of nocturia in men with lower urinary tract symptoms allocated to placebo during a 12-month randomized, controlled trial.
C. Vaughan (2014)
Medication adherence in the management of nocturia: challenges and solutions
R. Jayadevappa (2015)
Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real‐life practice
S. Chen (2016)
Overactive bladder in clinical practice and future neuromodulation treatments
H.M.K. van Breda (2017)
Self‐rated sleep characteristics and bother from nocturia
C. Vaughan (2012)
The Etiologic Classification of Nocturia among 133 Thai Patients in a Tertiary Teaching Hospital
Supanat Sirikulchayanonta (2013)
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis.
J. Cornu (2012)
Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement.
C. Welliver (2015)
UROLOGIC PROBLEMS IN THE ELDERLY POPULATION YAfiLI TOPLUMDA ÜROLOJ
Yavuz Akman (2013)
An Investigation into the Significance and Effect of Bowel and Bladder Dysfunction on Personal Burden for People Who Have Parkinson’s Disease
Joanne Lawrence (2014)
Exploring nocturia: Gender, age, and causes
An-Sofie Goessaert (2015)
A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders
R. Sakakibara (2016)
Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.
Kara Suvada (2020)
A. Bergman (2012)